Table 1 Major clinicopathologic characteristics of the 100 PC patients
Items | Value, n (%) |
|---|---|
Gender | |
 Male/female | 41 (41)/59 (59) |
Age (years) | |
 <60/≥60 | 71 (71)/29 (29) |
Median KPS score (range) | 70 (60–90) |
Primary tumor | |
 Carcinoma of the stomach | 30 (30) |
 Carcinoma of the colorectum | 41 (41) |
 Pseudomyxoma peritonei | 13 (13) |
 Carcinoma of ovary and primary peritoneum | 16 (16) |
Histopathology | |
 Adenocarcinoma, poorly/intermediately differentiated | 44 (44) |
 Undifferentiated carcinoma | 3 (3) |
 Myxoadenocarcinoma and signet-ring cell carcinoma | 26 (26) |
 Serous adencarcinoma | 14 (14) |
 Pseudomyxoma peritonei | 13 (13) |
Neoadjuvant chemotherapy | |
 Yes/no | 47 (47)/53 (53) |
PC timinga | |
 Synchronous/metachronous | 80 (80)/20 (20) |
PCI scoresa | |
 ≤20/>20 | 44 (44)/56 (56) |
 Median PCI scores (range) | 22 (3–39) |
Ascites at surgeryb | |
 ≤1000 mL/>1000 mL | 63 (63)/37 (37) |
Surgical procedures-organ resection | |
 Partial/total gastrectomy | 24 (24) |
 Resection of jejunum | 4 (4) |
 Resection of ileum | 12 (12) |
 Resection of ileocecus | 32 (32) |
 Ascending colectomy | 27 (27) |
 Transverse colectomy | 32 (32) |
 Descending colectomy | 12 (12) |
 Sigmoidectomy | 16 (16) |
 Rectectomy | 29 (29) |
 Resection ovarian/fallopian tube | 29 (29) |
 Hysterectomy | 15 (15) |
 Partial hepatectomy | 2 (2) |
 Splenectomy | 11 (11) |
 Cholecystectomy | 11 (11) |
Number of organ resecteda,c | |
 1–3 resections | 59 (67.1) |
 4–7 resections | 23 (26.1) |
 8–12 resections | 6 (6.8) |
Peritonectomya | |
 Greater/lesser omentum | 92 (92) |
 Left diaphragmatic copula | 15 (15) |
 Right diaphragmatic copula | 38 (38) |
 Right colon gutter | 41 (41) |
 Left colon gutter | 42 (42) |
 Liver round ligament/sickle ligament | 53 (53) |
 Douglas/rectovesical pouch | 49 (49) |
 Anterior wall peritoneum | 40 (40) |
 Pelvic peritoneum | 58 (58) |
 Mesenteric fulguration | 66 (66) |
Peritoneal resection areaa | |
 1–3 resections | 44 (44) |
 4–6 resections | 16 (16) |
 7–12 resections | 40 (40) |
CC scoresa | |
 0 | 30 (30) |
 1 | 32 (32) |
 2–3 | 38 (38) |
Number of anastomosisa | |
 None or ostomy only | 25 (25) |
 =1/>1 | 35 (35)/40 (40) |
Postoperative chemotherapy moded | |
 SC/SC + IP | 31 (38.3)/50 (61.7) |
Postoperative chemotherapy cycles | |
 <6/≥6 | 49 (49)/51 (51) |
Median postoperative chemotherapy cycles (range) | 6 (1–12) |
 Median postoperative SC/IP + SC cycles (range)d | 5 (1–12)/6 (1–12) |
Median duration of ICU (hours) (range) | 22 (11–94) |
Median duration of hospitalization (days) (range) | 20 (10–76) |
 Median follow-up (months) (range) | 19.7 (7.5–89.2) |